HIV RESEARCH CORE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 加州大学约翰·A·伯恩斯医学院的夏威夷艾滋病临床研究项目(HACRP)将艾滋病毒研究核心纳入其中。HACRP设在Leahi医院，根据以下具体目标强调艾滋病毒教育、研究和服务： 1)发展临床研究能力，以评估艾滋病毒-1感染和艾滋病相关并发症的最佳治疗方法。 2)为夏威夷所有感染HIV-1的患者提供临床研究、试验和研究。 3)促进将研究成果转化为临床护理，最终将改善艾滋病毒-1感染者的生活质量。 HACRP还包括夏威夷艾滋病临床试验单位(HACTU)和神经艾滋病专门神经科学研究计划(神经艾滋病SNRP)。 与HACRP的这种联系与UH CRC计划的具体目标是一致的，即建立和完善在早期人类发育、生物营养、艾滋病毒和癌症方面的卓越临床和专业知识，特别强调与夏威夷人口临床相关的问题。此外，与HACRP共同开发的艾滋病毒研究核心证明了研究合作和伙伴关系，这将进一步加强夏威夷大学竞争NIH机构临床翻译科学奖(CTSA)的能力。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The UH CRC program has expanded to include a HIV Research Core in affiliation with the Hawaii AIDS Clinical Research Program (HACRP) of the UH John A. Burns School of Medicine. Located at Leahi Hospital, the HACRP emphasizes HIV education, research, and service in accordance with the following specific aims: 1) To develop clinical research capabilities to evaluate optimal therapies for HIV-1 infection and AIDS-associated complications. 2) To provide access to clinical research, trials, and studies for all HIV-1 infected patients in Hawaii. 3) To facilitate the transfer of research findings to clinical care which will ultimately improve the quality of life for patients with HIV-1 infection. THe HACRP also includes the Hawaii AIDS Clinical Trials Unit (HACTU) and the NeuroAIDS Specialized Neuroscience Research Program (NeuroAIDS SNRP). This affiliation with the HACRP is in congruence with the specific aims of the UH CRC program, namely, to build and refine clinical excellence and expertise in Early Human Development, Bionutrition, HIV and Cancer, with particular emphasis on issues of clinical relevance to the populations of the State of Hawaii. Moreover, the development of the HIV Research Core with the HACRP gives evidence of research collaboration and partnership which will further strengthen the University of Hawaii's ability to compete for a NIH institutional Clinical Translational Science Award (CTSA).